Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 25120250)

1.
2.

Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M.

Eur J Cancer. 2013 Oct;49(15):3140-8. doi: 10.1016/j.ejca.2013.05.027. Epub 2013 Jul 4.

PMID:
23831335
3.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
4.

Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.

Vaira M, Robella M, Mellano A, Sottile A, De Simone M.

Int J Hyperthermia. 2014 Dec;30(8):565-9. doi: 10.3109/02656736.2014.974693.

PMID:
25430988
5.

Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.

Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V.

Eur J Surg Oncol. 2013 Nov;39(11):1207-13. doi: 10.1016/j.ejso.2013.08.017. Epub 2013 Sep 2.

PMID:
24007834
6.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH.

J Clin Oncol. 2009 Dec 20;27(36):6237-42. doi: 10.1200/JCO.2009.23.9640. Epub 2009 Nov 16.

7.

Treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery and HIPEC.

Robella M, Vaira M, Mellano A, Marsanic P, Cinquegrana A, Borsano A, Barbera M, Caneparo A, Siatis D, Sottile A, De Simone M.

Minerva Chir. 2014 Feb;69(1):9-15.

PMID:
24675242
8.

Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.

Chua TC, Quinn LE, Zhao J, Morris DL.

J Surg Oncol. 2013 Aug;108(2):81-8. doi: 10.1002/jso.23356. Epub 2013 Jun 5.

PMID:
23737041
9.

Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.

Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA.

J Am Coll Surg. 2012 Sep;215(3):412-7. doi: 10.1016/j.jamcollsurg.2012.04.023. Epub 2012 May 26.

10.

Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality.

Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, Levine EA.

Ann Surg Oncol. 2013 Oct;20(11):3497-503. doi: 10.1245/s10434-013-3053-z. Epub 2013 Jun 19.

11.

Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.

Wong JF, Tan GH, Wang W, Soo KC, Teo MC.

World J Surg. 2015 Feb 5. [Epub ahead of print]

PMID:
25651962
12.

Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Van Sweringen HL, Hanseman DJ, Ahmad SA, Edwards MJ, Sussman JJ.

Surgery. 2012 Oct;152(4):617-24; discussion 624-5. doi: 10.1016/j.surg.2012.07.027. Epub 2012 Sep 1.

PMID:
22943843
13.

Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.

Ann Surg Oncol. 2009 Feb;16(2):463-72. doi: 10.1245/s10434-008-0219-1. Epub 2008 Dec 12.

PMID:
19082859
14.

Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH 4th, Shen P, Levine EA, Votanopoulos KI.

J Surg Res. 2015 Mar 24. pii: S0022-4804(15)00314-5. doi: 10.1016/j.jss.2015.03.051. [Epub ahead of print]

PMID:
25881787
15.

Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.

Ann Surg Oncol. 2015 May;22(5):1716-21. doi: 10.1245/s10434-014-3985-y. Epub 2014 Aug 22.

PMID:
25145504
16.

The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S.

Ann Surg Oncol. 2013 Apr;20(4):1093-100. doi: 10.1245/s10434-012-2845-x. Epub 2013 Mar 2.

PMID:
23456386
17.
18.

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.

Chua TC, Yan TD, Morris DL.

J Surg Oncol. 2009 Feb 1;99(2):109-13. doi: 10.1002/jso.21177.

PMID:
19016259
19.

Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients.

Warschkow R, Tarantino I, Lange J, Müller SA, Schmied BM, Zünd M, Steffen T.

Patient Saf Surg. 2012 Jun 15;6(1):12. doi: 10.1186/1754-9493-6-12.

20.

Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Kuijpers AM, Mehta AM, Boot H, van Leerdam ME, Hauptmann M, Aalbers AG, Verwaal VJ.

Ann Oncol. 2014 Apr;25(4):864-9. doi: 10.1093/annonc/mdu031.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk